On July 1, the South Dakota Supreme Court issued a unanimous decision affirming summary judgment in favor of a life settlement investor, holding that the investor was entitled to retain the full $10 million death benefit under a life insurance policy that the insured’s estate had sought to void as an alleged stranger-originated life insurance (STOLI) arrangement.
Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive.
Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.
The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.
“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.
Related Posts
The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments
Updating the life expectancy of an insured throughout the life of a life settlement investment…
Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts
Yona Chesner, Head of Pensions Investment at Cartwright Pension Trusts, offers his take on the…
US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027
The regulation, which was introduced at the beginning of the year in the US, has…
Optimism for Stronger Second Half in the Life Settlement Tertiary Market
General pace of activity picking up after slow first quarter of 2026.
